- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Kilitch Drugs (India) Limited — Others, 16-08-2025: Copy of Newspaper Publication
16-08-2025 | 11:51 am
16-08-2025 | 11:51 am
Kilitch Drugs has released its financial results for the quarter ended June 30, 2025. Consolidated total income from operations reached ₹43.14 Cr, with a net profit after tax of ₹2.26 Cr. Standalone total income was ₹34.12 Cr, with a net profit after tax of ₹4.79 Cr. Consolidated Earnings Per Share (EPS) stood at ₹1.88. These results, approved by the Board on August 13, 2025, offer stakeholders key insights into the company's recent financial performance and operational health.
No comments yet. Be the first to comment!